Inventor · disambiguated record
Ronghui Lin
Also filed as: LIN RONGHUI
25 granted patents·1 pending application·216 citations·filing 2001–2020
95Inventor score
Files withJANSSEN PHARMACEUTICA NV20ORTHO MCNEIL PHARM INC2BATTISTA KATHLEEN A1CONNOLLY PETER J1HUANG SHENLIN1
Top patents by PatentIndex Score
26 records- 0196US9611332B2Antibodies to aripiprazole haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 4, 2017·18 cites·7 claims
- 0296US9494607B2Antibodies to aripiprazole and use thereofORTHO CLINICAL DIAGNOSTICS INC·Filed 2013·Granted Nov 15, 2016·17 cites·23 claims
- 0396US7541367B23-benzoimidazolyl-pyrazolopyridines useful in treating kinase disordersJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Jun 2, 2009·104 cites·38 claims
- 0495US9795685B2Haptens of aripiprazoleJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Oct 24, 2017·17 cites·44 claims
- 0592US9504682B2Haptens of aripiprazoleJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Nov 29, 2016·17 cites·13 claims
- 0686US7317031B2Substituted triazole diamine derivatives as kinase inhibitorsORTHO MCNEIL PHARM INC·Filed 2005·Granted Jan 8, 2008·5 cites·11 claims
- 0783US7579356B2Thia-tetraazaacenaphthylene kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Aug 25, 2009·9 cites·27 claims
- 0883US6924302B2Substituted triazole diamine derivatives as kinase inhibitorsORTHO MCNEIL PHARM INC·Filed 2001·Granted Aug 2, 2005·21 cites·12 claims
- 0979US9611259B2Substituted pyridine derivatives useful as C-FMS kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Apr 4, 2017·3 cites·13 claims
- 1078US10175257B2Antibodies to aripiprazole and use thereofJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jan 8, 2019·1 cites·19 claims
- 1175US7888380B21,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide derivativesJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Feb 15, 2011·2 cites·27 claims
- 1272US11105793B2Antibodies to aripiprazole haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Aug 31, 2021·0 cites·11 claims
- 1371US10816561B2Antibodies to aripiprazole and use thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Oct 27, 2020·0 cites·26 claims
- 1471US7605154B2Substituted Thiazolo [4,5-d]pyrimidines as protein kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Oct 20, 2009·2 cites·5 claims
- 1569US11214566B2Substituted pyridine derivatives useful as C-FMS kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Jan 4, 2022·0 cites·12 claims
- 1666US10488401B2Antibodies to aripiprazole haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Nov 26, 2019·0 cites·15 claims
- 1763US10379105B2Antibodies to aripiprazole haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Aug 13, 2019·0 cites·8 claims
- 1862US10800764B2Substituted pyridine derivatives useful as C-FMS kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Oct 13, 2020·0 cites·10 claims
- 1960US10071991B2Substituted pyridine derivatives useful as c-fms kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Sep 11, 2018·0 cites·3 claims
- 2059US10166296B2Haptens of aripiprazoleJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jan 1, 2019·0 cites·9 claims
- 2150US7635703B2Imidazole substituted pyrazole kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Dec 22, 2009·0 cites·6 claims
- 2249US7638518B2Substituted pyrazole kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Dec 29, 2009·0 cites·6 claims
- 2347US8314234B2Bicyclic pyrimidine kinase inhibitorsCONNOLLY PETER J·Filed 2007·Granted Nov 20, 2012·0 cites·7 claims
- 2446US7109220B2Amino substituted pyridinyl methanone compounds useful in treating kinase disordersJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Sep 19, 2006·0 cites·10 claims
- 2543US8299082B21,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivativesHUANG SHENLIN·Filed 2010·Granted Oct 30, 2012·0 cites·2 claims
- 2643US2008108611A1Substituted thienopyrimidine kinase inhibitorsBATTISTA KATHLEEN A·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ronghui Lin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →